AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Importance of MRD Negativity in Myeloma and Trial-Level Surrogacy Analysis
This chapter emphasizes the benefits of achieving minimal residual disease negativity in myeloma patients and explores the concept of trial-level surrogacy to analyze correlations between MRD, progression-free survival, and overall survival. It also discusses advancements in measuring MRD in myeloma patients using more sensitive detection technologies.